In vivo evaluation of the effect of five disintegrants on the bioavailability of frusemide from 40mg tablets [proceedings].
D000293:Adolescent; D000328:Adult; D001682:Biological Availability; D005079:Excipients / Q000494:pharmacology; D005665:Furosemide / Q000008:administration & dosage / Q000378:metabolism*; D006801:Humans; D008297:Male; D012995:Solubility; D013607:Tablets
D005079:Excipients; D013607:Tablets; D005665:Furosemide